What development phase is Convenia in?

Convenia is FDA-approved (marketed).

What are the side effects of Convenia?

Common side effects include Elevated post-study BUN, Elevated serum gamma glutamyl transferase, Elevated serum alanine aminotransferase, Elevated post-study ALT, Elevated post-study creatinine, Diarrhea.

What is the generic name of Convenia?

CEFOVECIN is the generic (nonproprietary) name of Convenia.

Last reviewed 2026-04-20 · How we verify

Convenia (CEFOVECIN)

FDA-approved active Small molecule Quality 0/100

Convenia (CEFOVECIN) is a veterinary antibiotic originally developed by Pfizer and currently owned by Zoetis. It is a small molecule antibiotic used to treat various bacterial infections in dogs and cats. Convenia is FDA-approved for several indications, including skin infections, urinary tract infections, and respiratory infections. It is a patented product, and its commercial status is not off-patent. Key safety considerations include potential side effects such as vomiting, diarrhea, and skin reactions.

At a glance

Generic name	CEFOVECIN
Modality	Small molecule
Therapeutic area	Metabolic
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

Elevated post-study BUN
Elevated serum gamma glutamyl transferase
Elevated serum alanine aminotransferase
Elevated post-study ALT
Elevated post-study creatinine
Diarrhea

Serious adverse events

Death
Anaphylaxis
Acute pulmonary edema
Seizures
Tremors/ataxia
Hemolytic anemia
Facial edema
Injection site necrosis
Vomiting
Lethargy

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Convenia CI brief — competitive landscape report
Convenia updates RSS · CI watch RSS